In the ever-evolving field of medical innovation, vascular intervention, and electrophysiology have become more and more dynamic. From minimally invasive vascular treatment to sophisticated 3D mapping and ablation solutions, advances in medical devices and therapeutic innovations go hand in hand, impacting how we diagnose and treat.
This June, APT Medical proudly participated as a Ruby sponsor at MLCTO 2023, held in the picturesque city of Nice, France. The event was a huge success, gathering over 700 participants, among them more than 500 medical professionals.
APT Medical is delighted to announce our participation in the anticipated MLCTO 2023, which will take place in Nice, France from June 28th to July 1st, and we are proud to be the Ruby sponsor again after great success last year. In addition, we are excited to announce our partnership with MLCTO for the exclusive sponsored symposium on June 28th.
APT Medical is delighted to share our exceptional experience at EuroPCR 2023 held in Paris, France on May 4-6. The event brought together renowned professionals and industry experts in the field of interventional cardiology. APT Medical extends its sincerest gratitude to everyone who joined us at our booth, explored our innovative product portfolio, and contributed to the success of the event.
APT Medical is delighted to announce a significant milestone in our journey of growth and international expansion. We are proud to declare the official opening of PT. APT Medical Indonesia, our first overseas subsidiary, located in the vibrant city of Jakarta, Indonesia.